Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat and calponin homology domain-containing protein 4 (**LRCH4**) is a membrane-associated protein characterized by an N-terminal leucine-rich repeat (LRR) ectodomain that forms a horseshoe-like structure involved in ligand capture, a central intrinsically disordered region, and a C-terminal calponin homology (CH) domain, often accompanied by a transmembrane segment. LRCH4 plays a regulatory role in innate immune signaling and is necessary for optimal activation of Toll-like receptor 4 (TLR4) in response to bacterial lipopolysaccharide (LPS). It contributes to downstream induction of both MyD88-dependent and TRIF-dependent cytokines, as well as activation of transcription factors such as NF-κB and IRF3 after LPS exposure. LRCH4 is hypothesized to mediate organization and activity within lipid raft microdomains, possibly facilitating efficient TLR4 clustering and signaling. Additionally, LRCH4 interacts with cytoskeletal partner proteins (such as Coro1A) and may impact cell division, proliferation, and actin dynamics as part of broader cellular functions. While not itself a conventional receptor, LRCH4 acts as an accessory or scaffold protein in innate immune receptor complexes. It is widely expressed, evolutionarily conserved, and currently under study as a potential molecular target in inflammatory and infectious diseases.
Not applicable; no direct drugs currently interact with LRCH4. Mechanistically, future drugs might aim to modulate innate immune signaling or TLR4 pathway if targeting LRCH4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat and calponin homology domain-containing protein 4 (LRCH4).